ValenzaBio, Inc

ValenzaBio, Inc is a late-stage clinical biopharmaceutical company based in Bethesda, MD. They are dedicated to accelerating the development and delivery of transformative medicines for patients. With a team of knowledgeable and results-oriented experts, they work with a sense of urgency to identify and acquire innovative therapies that have the potential to make a clinically meaningful difference in immunology and other disease areas.

ValenzaBio, Inc is actively exploring the potential of their pipeline programs, including izokibep and lonigutamab, to address unmet patient needs and provide differentiated inhibition of validated targets. Led by a team of veteran biopharma executives, they are committed to building an innovative biopharma company that invests in, develops, and commercializes life-changing drug therapies.

Generated from the website